Connected medication compliance monitoring solutions in Europe to reach 2.2 million by 2022
Gothenburg, Sweden - December 7, 2017 (Investorideas.com Newswire) According to a new research report from the leading IoT analyst firm Berg Insight, the market for medication compliance monitoring solutions is still in an early stage with an estimated 138,000 connected devices in use in EU28+2 at the end of 2016. However, there are several promising business models for medication adherence solutions that are rolling out on the market. Berg Insight forecasts that the number of connected medication compliance monitoring solutions in EU28+2 will grow at a CAGR of 58 percent to reach 2.2 million by 2022.
"Substantial business opportunities are emerging for solutions targeted at the social care sector. There is an opportunity to leverage medication dispensing solutions as a replacement for manual labour. Many patients rely on frequent visits from their home care provider for medication dispensing. Many of these visits can be reduced or eliminated through the use of medication dispensing solutions", says Martin Bäckman, IoT Analyst, Berg Insight.
Pharmaceutical companies have launched the first connected medication monitoring solutions that are bundled together with specific drugs. In this market, increased adherence can improve treatment outcomes as well as increase the sale of prescription medications. The costs of an adherence monitoring system can in many cases be offset by a small increase in the sale of drugs. Furthermore, monitoring solutions can be very useful for drugs that have side effects or limited efficiency when adherence is poor.
Another target market is payers, which can reduce their total healthcare expenditures by decreasing indirect costs that arise from non-compliance. A barrier to adoption in this market may still be the limited clinical proof available on the positive effects that a specific adherence solution has on the total healthcare costs.
The Netherlands became the first country to implement a reimbursement code for medication dispensing, enabling home care providers to use a remotely monitored medication dispensing solution to replace some home visits. There is also strong interest from home care providers and municipalities for this use case in the Nordic countries.
About Berg Insight
Berg Insight is a dedicated M2M/IoT market research firm based in Sweden. We have been specialising in all major M2M/IoT verticals such as fleet management, car telematics, smart metering, smart homes, mHealth and industrial M2M since 2004. Our vision is to be the most valuable source of intelligence for our customers. Berg Insight offers numerous market reports, detailed market forecast databases and advisory services. We provide custom research tailored to your requirements including focussed research papers, business case analysis, go-to-market strategies and bespoke market forecasting. We have provided analytical services to 850 clients in 70 countries on six continents to date. Our customers range from many of the world’s largest mobile operators, IT companies and telecom vendors, to venture capitalists, technology start-ups and specialist consultants.
For additional information, please contact:
Johan Fagerberg, CEO
Phone: +46 31 711 30 91
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.